Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.82% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.26% |
| 4 | Consumer Discretionary | 1.92% |
| 5 | Industrials | 1.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
PUT
ConocoPhillips
COP
$151B
| $263M | 0.07% |
2,927,748
+524,000
| +22% | +$54M |
|
202
PUT
Deere & Co
DE
$167B
| $260M | 0.07% |
869,100
-286,300
| -25% | -$105M |
|
|
TWTR
203
CALL
DELISTED
Twitter, Inc.
TWTR
| $260M | 0.07% |
6,950,600
+313,300
| +5% | +$13.4M |
|
204
CALL
Oracle
ORCL
$419B
| $260M | 0.07% |
3,719,400
+562,000
| +18% | +$41.1M |
|
205
American Tower
AMT
$79B
| $260M | 0.07% |
1,015,902
+975,170
| +2,394% | +$245M |
|
206
PUT
Moderna
MRNA
$24.2B
| $260M | 0.07% |
1,817,300
-1,465,600
| -45% | -$209M |
|
207
PUT
Enphase Energy
ENPH
$5.59B
| $260M | 0.07% |
1,329,600
+367,200
| +38% | +$66.4M |
|
208
Bank of America
BAC
$448B
| $259M | 0.07% |
8,317,956
+504,718
| +6% | +$18.2M |
|
209
CALL
iShares MSCI EAFE ETF
EFA
$79.9B
| $258M | 0.07% |
4,135,100
+445,900
| +12% | +$30.3M |
|
210
PUT
PepsiCo
PEP
$189B
| $258M | 0.07% |
1,549,400
-212,200
| -12% | -$35.7M |
|
211
Mondelez International
MDLZ
$78.9B
| $258M | 0.07% |
4,154,314
+2,243,066
| +117% | +$142M |
|
212
CALL
Morgan Stanley
MS
$338B
| $258M | 0.07% |
3,385,800
+102,800
| +3% | +$8.42M |
|
213
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.4B
| $257M | 0.07% |
3,462,100
+302,300
| +10% | +$22.7M |
|
214
PUT
United States Oil Fund
USO
$1.8B
| $256M | 0.07% |
3,185,860
+89,076
| +3% | +$7.22M |
|
|
215
CALL
AT&T
T
$168B
| $256M | 0.07% |
12,199,700
-5,209,311
| -30% | -$104M |
|
216
CALL
Diamondback Energy
FANG
$56.5B
| $256M | 0.07% |
2,109,800
+225,700
| +12% | +$30.9M |
|
217
PUT
Airbnb
ABNB
$111B
| $252M | 0.06% |
2,833,000
+45,900
| +2% | +$5.97M |
|
218
CALL
GameStop
GME
$8.44B
| $252M | 0.06% |
8,246,400
-6,194,800
| -43% | -$197M |
|
219
CALL
Bristol-Myers Squibb
BMY
$130B
| $252M | 0.06% |
3,274,200
-58,900
| -2% | -$4.49M |
|
220
PUT
State Street SPDR S&P Regional Banking ETF
KRE
$4.61B
| $252M | 0.06% |
4,336,900
+1,046,800
| +32% | +$65.4M |
|
221
CALL
Union Pacific
UNP
$174B
| $251M | 0.06% |
1,176,300
+71,200
| +6% | +$16.2M |
|
222
PUT
Snowflake
SNOW
$116B
| $250M | 0.06% |
1,796,800
+112,200
| +7% | +$17.8M |
|
223
CALL
Roku
ROKU
$22.4B
| $249M | 0.06% |
3,035,100
+312,000
| +11% | +$30.2M |
|
224
IQVIA
IQV
$40.1B
| $249M | 0.06% |
1,145,827
+395,941
| +53% | +$86M |
|
225
CALL
MongoDB
MDB
$35.3B
| $246M | 0.06% |
946,600
+349,200
| +58% | +$109M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.